FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313891506> ?p ?o ?g. }

• W4313891506 abstract "Objectives The objective of this study was to characterize a population of patients with severe tricuspid regurgitation (TR) evaluated at a tertiary care center, assess mid-term clinical outcomes, and identify prognostic factors. Background The impact of TR on morbidity and mortality is increasingly recognized. Clinical characteristics and long-term outcomes of patients suffering from TR remain unclear. Methods This is a retrospective observational single-center study from a tertiary care hospital including patients with echocardiographic diagnosis of severe TR between January 2017 and December 2018. We used the Kaplan–Meier method to estimate survival for up to 4 years. After excluding patients with tricuspid valve (TV) intervention and surgery during follow-up, a multivariate analysis was performed to assess predictors of 2-year mortality using the Cox regression model. Results A total of 278 patients (mean age 74.9 ± 13.7 years, 47.8% female) with severe TR were included in the study. The majority (83.1%; n = 231) had secondary TR. Comorbidities such as atrial fibrillation (AFib) (68.0%; n = 189), severe renal failure (44.2%; n = 123), pulmonary hypertension (PHT) (80.9%; n = 225), and right ventricular (RV) dysfunction (59.7%; n = 166) were highly prevalent. More than half of patients with a cardiac implantable electronic device (CIED) (54.3%; n = 44) showed echocardiographic signs of lead-leaflet interaction causing or contributing to TR. The estimated 2- and 4-year all-cause mortality was 50 and 69%, respectively. Using multivariate analysis, age, severe renal failure, heart failure with reduced ejection fraction (HFrEF), and vena contracta width ≥14 mm were identified as predictors of 2-year mortality. Nine percent ( n = 25) of the study cohort underwent transcatheter or surgical treatment for TR during follow-up. Conclusion Our study shows the high burden of morbidity and the dismal survival of patients with severe TR. It also highlights the extent of the therapeutic need, since the vast majority of patients were left untreated. Additionally, CIED RV lead-associated TR was prevalent suggesting a need for more attention in clinical routine and research." @default.
• W4313891506 created "2023-01-10" @default.
• W4313891506 creator A5013414187 @default.
• W4313891506 creator A5015879096 @default.
• W4313891506 creator A5016167046 @default.
• W4313891506 creator A5017333899 @default.
• W4313891506 creator A5018822551 @default.
• W4313891506 creator A5019587141 @default.
• W4313891506 creator A5033654337 @default.
• W4313891506 creator A5036512275 @default.
• W4313891506 creator A5041250456 @default.
• W4313891506 creator A5050309821 @default.
• W4313891506 creator A5053194091 @default.
• W4313891506 creator A5074173630 @default.
• W4313891506 date "2023-01-09" @default.
• W4313891506 modified "2023-10-14" @default.
• W4313891506 title "Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort study" @default.
• W4313891506 cites W2014277497 @default.
• W4313891506 cites W2064308817 @default.
• W4313891506 cites W2085833429 @default.
• W4313891506 cites W2101825249 @default.
• W4313891506 cites W2111183899 @default.
• W4313891506 cites W2122694177 @default.
• W4313891506 cites W2124624517 @default.
• W4313891506 cites W2141071883 @default.
• W4313891506 cites W2149609916 @default.
• W4313891506 cites W2166169791 @default.
• W4313891506 cites W2320421904 @default.
• W4313891506 cites W2338067807 @default.
• W4313891506 cites W2596797126 @default.
• W4313891506 cites W2605849388 @default.
• W4313891506 cites W2611089540 @default.
• W4313891506 cites W2735825255 @default.
• W4313891506 cites W2751630023 @default.
• W4313891506 cites W2885306372 @default.
• W4313891506 cites W2893350115 @default.
• W4313891506 cites W2900081037 @default.
• W4313891506 cites W2919243477 @default.
• W4313891506 cites W2919376078 @default.
• W4313891506 cites W2936686306 @default.
• W4313891506 cites W2939812704 @default.
• W4313891506 cites W2943841851 @default.
• W4313891506 cites W2954576217 @default.
• W4313891506 cites W2967831003 @default.
• W4313891506 cites W2972579749 @default.
• W4313891506 cites W2989249686 @default.
• W4313891506 cites W3025388713 @default.
• W4313891506 cites W3128573593 @default.
• W4313891506 cites W3162474603 @default.
• W4313891506 cites W3170182434 @default.
• W4313891506 cites W3195842247 @default.
• W4313891506 cites W4200030511 @default.
• W4313891506 cites W4206388076 @default.
• W4313891506 cites W4206742799 @default.
• W4313891506 cites W4210454326 @default.
• W4313891506 cites W4220668251 @default.
• W4313891506 cites W4233594523 @default.
• W4313891506 doi "https://doi.org/10.3389/fcvm.2022.1026230" @default.
• W4313891506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36698931" @default.
• W4313891506 hasPublicationYear "2023" @default.
• W4313891506 type Work @default.
• W4313891506 citedByCount "0" @default.
• W4313891506 crossrefType "journal-article" @default.
• W4313891506 hasAuthorship W4313891506A5013414187 @default.
• W4313891506 hasAuthorship W4313891506A5015879096 @default.
• W4313891506 hasAuthorship W4313891506A5016167046 @default.
• W4313891506 hasAuthorship W4313891506A5017333899 @default.
• W4313891506 hasAuthorship W4313891506A5018822551 @default.
• W4313891506 hasAuthorship W4313891506A5019587141 @default.
• W4313891506 hasAuthorship W4313891506A5033654337 @default.
• W4313891506 hasAuthorship W4313891506A5036512275 @default.
• W4313891506 hasAuthorship W4313891506A5041250456 @default.
• W4313891506 hasAuthorship W4313891506A5050309821 @default.
• W4313891506 hasAuthorship W4313891506A5053194091 @default.
• W4313891506 hasAuthorship W4313891506A5074173630 @default.
• W4313891506 hasBestOaLocation W43138915061 @default.
• W4313891506 hasConcept C126322002 @default.
• W4313891506 hasConcept C163276114 @default.
• W4313891506 hasConcept C164705383 @default.
• W4313891506 hasConcept C167135981 @default.
• W4313891506 hasConcept C2778198053 @default.
• W4313891506 hasConcept C2779161974 @default.
• W4313891506 hasConcept C2779946567 @default.
• W4313891506 hasConcept C2780073493 @default.
• W4313891506 hasConcept C2780168065 @default.
• W4313891506 hasConcept C2780930700 @default.
• W4313891506 hasConcept C2908647359 @default.
• W4313891506 hasConcept C38180746 @default.
• W4313891506 hasConcept C50382708 @default.
• W4313891506 hasConcept C71924100 @default.
• W4313891506 hasConcept C72563966 @default.
• W4313891506 hasConcept C78085059 @default.
• W4313891506 hasConcept C99454951 @default.
• W4313891506 hasConceptScore W4313891506C126322002 @default.
• W4313891506 hasConceptScore W4313891506C163276114 @default.
• W4313891506 hasConceptScore W4313891506C164705383 @default.
• W4313891506 hasConceptScore W4313891506C167135981 @default.
• W4313891506 hasConceptScore W4313891506C2778198053 @default.
• W4313891506 hasConceptScore W4313891506C2779161974 @default.
• W4313891506 hasConceptScore W4313891506C2779946567 @default.

• next